Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial.

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial.

OBJECTIVES:Systemic sclerosis (SSc) is an auto-immune, multi organ disease marked by severe gastrointestinal (GI) involvement and gut dysbiosis. Here, we aimed to determine the safety and efficacy of fecal microbiota transplantation (FMT) using commercially-available anaerobic cultivated human intes...

Full description

Bibliographic Details
Main Authors: Håvard Fretheim, Brian K Chung, Henriette Didriksen, Espen S Bækkevold, Øyvind Midtvedt, Cathrine Brunborg, Kristian Holm, Jørgen Valeur, Anders Heiervang Tennøe, Torhild Garen, Tore Midtvedt, Marius Trøseid, Hasse Zarè, May Brit Lund, Johannes R Hov, Knut E A Lundin, Øyvind Molberg, Anna-Maria Hoffmann-Vold
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0232739

Internet

https://doi.org/10.1371/journal.pone.0232739

Similar Items